MINI FUTURE LONG - ZEALAND PHARMA Share Price

DE000ME6R7A1

Real-time Bid/Ask 07:24:50 23/05/2024 pm IST
3.81 ^EUR / 3.86 ^EUR	+1.19%

Current month	-7.56%
1 month	+9.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZEALAND PHARMA A/S

Latest news about ZEALAND PHARMA A/S

Nordic Stocks Declined Thursday; Zealand Pharma Took Biggest Hit	16/05	DJ
Zealand Pharma A/S : Q1 2024 Financial Results	16/05	PU
Transcript : Zealand Pharma A/S, Q1 2024 Earnings Call, May 16, 2024	16/05
Zealand Pharma Announces Financial Results for the First Quarter of 2024	16/05	GL

More news

Quotes 5-day view

Date	Price	Change
23/24/23	3.9	+2.90%
22/24/22	3.79	+0.80%
21/24/21	3.76	+3.87%
20/24/20	3.62	-1.09%
17/24/17	3.66	-4.69%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 07:05 pm IST

More quotes

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	CALL
Underlying	ZEALAND PHARMA A/S
Issuer	Morgan Stanley
WKN	ME6R7A
ISIN	DE000ME6R7A1
Date issued	10/01/2024
Strike	319.5 kr
Maturity	Unlimited
Parity	10 : 1
Emission price	1.17 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	6.01 €
Lowest since issue	1.35 €
Spread	0.05 €
Spread %	1.27%

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Sector

More about the company

Ratings for Zealand Pharma A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Zealand Pharma A/S

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

613.5 DKK

Average target price

785.6 DKK

Spread / Average Target

+28.05%

Consensus